Maine recalls

Teva Pharmaceuticals discovered that some bottles of trazodone 50 mg tablets contain foreign tablets or capsules mixed in with the correct medication. The issue affects one lot (1394026) with an expiration date of February 2028. No injuries have been reported.

Supernus Pharmaceuticals is recalling one lot of Trokendi XR (topiramate) 50 mg extended-release capsules because the medication did not dissolve as designed. When a medication fails to dissolve properly, the body may not absorb the full dose, potentially reducing its effectiveness.

Mylan Pharmaceuticals is recalling specific lots of Mycophenolate Mofetil for injection (500 mg/vial) because the medication failed to meet dissolution specifications—meaning the drug may not dissolve properly in the body. This could affect how well the medicine works. The recall affects two lots distributed nationwide.

Testing by Allies Group found that certain batches of The ONE SPF 50 Invisible Sunscreen Gel may not provide the SPF 50 sun protection stated on the label. The affected product was distributed nationwide in the U.S. No injuries have been reported.

Testing found that Allies Group THE ONE SPF 50 Invisible Sunscreen Gel may not provide the advertised SPF 50 sun protection. The product was distributed nationwide in the U.S. The affected sunscreen was made in the U.S.A and distributed by Allies Group Pte Ltd.

Testing found that THE ONE SPF 50 Invisible Sunscreen Gel sachets may not provide the SPF 50 sun protection stated on the label. The affected product was distributed nationwide in the U.S. No injuries have been reported.

Testing by Allies Group Inc. found that The One SPF 50 Invisible Sunscreen Gel may not provide the full SPF 50 sun protection stated on the label. The affected product was distributed nationwide in the U.S. across multiple lot codes with expiration dates through June 2029.

Bionpharma Inc. is recalling Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets (10 mg/10 mg, 100-count bottles) because some bottles contain unidentified foreign tablets or capsules mixed in with the correct medication. The affected lot is DMA25006 with an expiration date of 11/30/2028. This issue was discovered during quality control.

Baxter Healthcare is recalling one lot of Daptomycin in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practice (CGMP) standards during production. The affected lot (NC193856, expiring 04/18/2028) was distributed nationwide, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Vancomycin Injection (NDC 0338-3583-01, Lot #NC193894) due to deviations from good manufacturing practices (CGMP). The affected lot was distributed nationwide in the US, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling three lots of Vasopressin injection due to manufacturing process deviations that do not meet FDA quality standards. The affected lots were distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose due to deviations from manufacturing quality standards. The affected lot was distributed nationwide, in Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Clindamycin Injection USP in 5% Dextrose (900 mg/50 mL) due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling a specific lot of Clindamycin Phosphate in 0.9% Sodium Chloride Injection due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lot (NC193689, expiring 10/16/2027) was distributed nationwide, as well as to Puerto Rico and Chile.

Baxter Healthcare has recalled three specific lots of Clindamycin Injection USP (900 mg per 50 mL) due to deviations from Good Manufacturing Practice (CGMP) standards during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare has recalled multiple lots of Nexterone (amiodarone HCI) injection due to deviations from good manufacturing practices (CGMP) during production. The affected lots were distributed nationwide, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare has recalled specific lots of CARDENE IV (nicardipine hydrochloride) injection due to deviations from manufacturing quality standards. The affected lots were distributed in the United States, Puerto Rico, and Chile.

Baxter Healthcare Corporation is recalling one lot of Pantoprazole Sodium in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed in the United States, Puerto Rico, and Chile.

Baxter Healthcare is recalling specific lots of Vasopressin injection due to deviations from manufacturing standards (CGMP). The affected lots may not meet required quality and purity standards. This is a precautionary recall of a medication used in hospitals and clinical settings.

Baxter Healthcare Corporation is recalling specific lots of dexmedetomidine hydrochloride injection due to deviations from current good manufacturing practice (CGMP) standards during production. The affected lots were distributed nationwide, in Puerto Rico, and Chile.

Baxter Healthcare is recalling two lots of famotidine injection (20 mg in 50 mL sodium chloride) due to deviations from manufacturing standards. The affected lots may not meet quality and sterility requirements.

Baxter Healthcare Corporation is recalling specific lots of Clindamycin Injection USP in 5% Dextrose due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lots are NC193764 (expiration 10/18/2027) and NC195232 (expiration 11/25/2027), distributed nationwide in the US, Puerto Rico, and Chile.

Baxter Healthcare is recalling one lot of Daptomycin in 0.9% Sodium Chloride Injection due to deviations from good manufacturing practices (CGMP) during production. The affected lot (NC188692, expiring 11/22/2027) was distributed nationwide, in Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare is recalling specific lots of MYXREDLIN (insulin human injection) due to deviations from current Good Manufacturing Practice (CGMP) standards during production. The affected lots were distributed in the US, Puerto Rico, and Chile. No injuries have been reported.

Baxter Healthcare Corporation is recalling five lots of Vancomycin Injection USP in 5% Dextrose due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The affected lots were distributed nationwide, in Puerto Rico, and Chile.

Golden State Medical Supply Inc. is recalling Prasugrel HCI 10mg tablets (lot GS062298, expiration 09/30/2026) because they failed to meet dissolution specifications during quality testing. Dissolution is how quickly a tablet breaks down in the body to release its active ingredient. Tablets that dissolve too slowly or incompletely may not work as intended.

BMC Medical Co., Ltd. recalled 20,160 Luna G3 APAP sleep apnea devices (Model LG3600) due to a firmware defect in version G3-2.00.76. Under certain high-pressure, high-breathing-rate conditions, affected devices can display an error message and shut down automatically, stopping therapy delivery. Most devices were corrected with a firmware upgrade, but up to 196 units may still contain the defective version.

Foods Alive Inc is recalling 8-ounce packages of organic moringa leaf powder because they may be contaminated with Salmonella. The contamination was discovered after the supplier's sample tested positive. No illnesses have been reported so far.

SUPPLX.com's Business Pill and Branch Manager for Men dietary supplements contain yohimbine that is not listed on the labels. FDA testing found dangerously high levels of this substance, which can cause serious heart problems, severe high blood pressure, and other dangerous side effects—especially in people taking stimulants or certain medications.

American Regent is recalling three lots of epinephrine injection (1 mg/mL multi-dose vials) due to leaking and cracked vials, plus contamination with particles including nylon, cellulosic, acrylic, polyethylene, and glass. These particles can block blood vessels, cause blood clots, and damage organs; cracked vials also risk loss of sterility and bacterial contamination. No adverse events have been reported so far.